Search

everythinglearnresearchcommunity

for

Search:↓

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

The medication lopinavir-ritonavir may cause severe hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

VB-1, a natural compound, may promote hair growth by enhancing important cell signaling and increasing key gene expression.

Cannabidivarin (CBDV) helps new brain cells grow and develop in a specific brain area through a certain receptor.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Encapsulated retinol may effectively treat actinic keratosis without side effects.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Valproic acid can cause dark lines on nails.

A man developed alopecia areata after starting cancer treatment with vandetanib.

The EFSA maintained its view that spermidine's effect on hair growth is related to disease treatment and does not meet the health claim criteria.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

The nicotinamide supplement did not reduce symptoms in horses with insect bite hypersensitivity.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Butin is effective in treating vitiligo in mice.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Deucravacitinib helped a man regrow hair significantly.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.